OpenAI acquires Orchestra Bio

来源摘要

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

摘要由机器生成（来自来源站点），可能存在偏差； 本站不转载全文，请以原文为准。